• CDC
  • Heart Failure
  • Cardiovascular Clinical Consult
  • Adult Immunization
  • Hepatic Disease
  • Rare Disorders
  • Pediatric Immunization
  • Implementing The Topcon Ocular Telehealth Platform
  • Weight Management
  • Monkeypox
  • Guidelines
  • Men's Health
  • Psychiatry
  • Allergy
  • Nutrition
  • Women's Health
  • Cardiology
  • Substance Use
  • Pediatrics
  • Kidney Disease
  • Genetics
  • Complimentary & Alternative Medicine
  • Dermatology
  • Endocrinology
  • Oral Medicine
  • Otorhinolaryngologic Diseases
  • Pain
  • Gastrointestinal Disorders
  • Geriatrics
  • Infection
  • Musculoskeletal Disorders
  • Obesity
  • Rheumatology
  • Technology
  • Cancer
  • Nephrology
  • Anemia
  • Neurology
  • Pulmonology

Gianotti-Crosti Syndrome

Article

Flesh-colored to red-brown nonpruritic papules developed most prominently on the elbows, forearms, and knees of a 2 1⁄2-year-old boy. The rash was preceded by a low-grade fever and mild, upper respiratory tract symptoms.

Flesh-colored to red-brown nonpruritic papules developed most prominently on the elbows, forearms, and knees of a 2 1⁄2-year-old boy. The rash was preceded by a low-grade fever and mild, upper respiratory tract symptoms.

On physical examination, no hepatosplenomegaly was detected. A clinical diagnosis of Gianotti-Crosti syndrome, or papular acrodermatitis, was made by Drs Charles E. Crutchfield III and Humberto Gallego of Eagan, Minn.

Gianotti-Crosti syndrome is self-limited. It is seen in children, particularly youngsters between 2 and 5 years of age who have viral infections, including those caused by Epstein-Barr virus, coxsackievirus, and hepatitis B virus. If hepatic symptoms are present at the initial diagnosis, reexamine the child in 4 to 6 weeks; patients without liver involvement need routine follow-up to monitor for the development of hepatic disorders.

Mild postinflammatory hyperpigmentation may follow rash resolution; generally, it will fade in a few months. Corticosteroids usually are of no benefit in treating this condition. Reassure the patient (and parents) that the disease is self-limited and will resolve in approximately 2 months. This young boy's symptoms cleared 7 weeks after they first appeared.

Related Videos
Infectious disease specialist talks about COVID-19 vaccine development
COVID 19 impact on healthcare provider mental health
Physician mental health expert discusses impact of COVID-19 on health care workers
© 2024 MJH Life Sciences

All rights reserved.